A detailed history of Spire Wealth Management transactions in Zomedica Corp. stock. As of the latest transaction made, Spire Wealth Management holds 220,500 shares of ZOM stock, worth $28,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares
220,500
Previous 224,173 1.64%
Holding current value
$28,665
Previous $33,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$0.12 - $0.16 $440 - $587
-3,673 Reduced 1.64%
220,500 $30,000
Q2 2024

Jul 31, 2024

BUY
$0.12 - $0.18 $26,317 - $39,475
219,310 Added 4509.77%
224,173 $33,000
Q1 2024

Apr 24, 2024

SELL
$0.12 - $0.19 $37 - $59
-314 Reduced 6.07%
4,863 $0
Q4 2023

Feb 06, 2024

BUY
$0.15 - $0.22 $39 - $57
262 Added 5.33%
5,177 $1,000
Q3 2023

Nov 08, 2023

SELL
$0.16 - $0.23 $13 - $19
-85 Reduced 1.7%
4,915 $0
Q2 2023

Aug 09, 2023

SELL
$0.19 - $0.22 $7 - $8
-40 Reduced 0.79%
5,000 $1,000
Q1 2023

May 09, 2023

SELL
$0.16 - $0.29 $8 - $15
-54 Reduced 1.06%
5,040 $1,000
Q4 2022

Feb 03, 2023

BUY
$0.16 - $0.25 $11 - $17
70 Added 1.39%
5,094 $1,000
Q3 2022

Nov 07, 2022

BUY
$0.2 - $0.38 $4 - $8
22 Added 0.44%
5,024 $1,000
Q2 2022

Jul 22, 2022

SELL
$0.2 - $0.34 $399 - $679
-1,998 Reduced 28.54%
5,002 $1,000
Q1 2022

Apr 18, 2022

SELL
$0.28 - $0.4 $448 - $640
-1,600 Reduced 18.6%
7,000 $2,000
Q4 2021

Jan 14, 2022

BUY
$0.31 - $0.58 $155 - $290
500 Added 6.17%
8,600 $3,000
Q3 2021

Oct 22, 2021

SELL
$0.46 - $0.81 $2,024 - $3,564
-4,400 Reduced 35.2%
8,100 $4,000
Q2 2021

Jul 26, 2021

BUY
$0.72 - $1.46 $2,160 - $4,380
3,000 Added 31.58%
12,500 $10,000
Q1 2021

May 21, 2021

BUY
$0.35 - $2.7 $3,325 - $25,650
9,500 New
9,500 $15,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.